BioCentury
ARTICLE | Clinical News

Ziagen abacavir regulatory update

March 9, 2009 7:00 AM UTC

FDA cautioned healthcare professionals against using skin patch testing to immunologically confirm suspected cases of hypersensitivity reactions in patients treated with abacavir. The agency said data...